$12.86
0.050.39%
At Close: -
$12.86
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Neumora Therapeutics (NASDAQ:NMRA) Stock, Earnings Estimates, EPS, And Revenue
Neumora Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 15
EPS Estimate
$-0.370
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Neumora Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NMRA | Neumora Therapeutics | -$1.14 | — | — | — | $0.00 | — | — | — | 10/30/2024 | Get Alert |
| NMRA | Neumora Therapeutics | — | -$0.37 | — | — | — | — | — | — | 08/15/2024 | Get Alert |
| NMRA | Neumora Therapeutics | -$1.22 | -$0.34 | -$0.34 | 0.00% | $0.00 | — | $0.00 | — | 05/07/2024 | Get Alert |
| NMRA | Neumora Therapeutics | -$0.99 | -$0.55 | -$0.71 | -29.09% | $0.00 | — | $0.00 | — | 03/07/2024 | Get Alert |
| NMRA | Neumora Therapeutics | -$1.06 | -$0.36 | -$1.14 | -216.67% | $0.00 | — | $0.00 | — | 11/01/2023 | Get Alert |
Neumora Therapeutics (NMRA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-07 | $-0.34 | $-0.34 | 0.00 % |
| Dec 2023 | 2024-03-07 | $-0.71 | $-0.55 | -29.1 % |
| Sep 2023 | 2023-11-01 | $-1.14 | $-0.36 | -216.7 % |
Neumora Therapeutics (NMRA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Neumora Therapeutics (NASDAQ:NMRA) reporting earnings?
Neumora Therapeutics (NMRA) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
What were the latest earnings per share (EPS) for Neumora Therapeutics (NASDAQ:NMRA)?
The Actual EPS was $-0.34, which hit the estimate of $-0.34.
What were Neumora Therapeutics’s (NASDAQ:NMRA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.